Laryngopharyngeal Reflux: Effect of Antireflux PPI Therapy on Nasal Congestion and Olfaction.

Vasiliki Florou, Nikos Kamargiannis, Ioannis Bizakis, Charalampos Skoulakis, Jiannis Hajiioannou
{"title":"Laryngopharyngeal Reflux: Effect of Antireflux PPI Therapy on Nasal Congestion and Olfaction.","authors":"Vasiliki Florou, Nikos Kamargiannis, Ioannis Bizakis, Charalampos Skoulakis, Jiannis Hajiioannou","doi":"10.26574/maedica.2024.19.3.486","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Laryngopharyngeal reflux (LPR) is responsible for many otorhinolaryngology manifestations. There is little evidence regarding the LPR impact on olfaction. No other study has investigated the efficacy of proton pump inhibitors (PPIs) on olfaction. We aimed to evaluate the effect of antireflux medication on olfaction and nasal patency in patients with LPR.</p><p><strong>Materials and methods: </strong>Thirty patients with LPR were recruited. Nasal symptoms were self-evaluated with NOSE and SNOT-22 surveys, while a taste visual analogue scale (VAS) was used for gustation. Olfaction was evaluated with Sniffin' Sticks test and nasal patency with anterior rhinomanometry. After 12 weeks of oral PPIs, the procedure was re-applied and clinical outcomes were compared.</p><p><strong>Results: </strong>Variables with statistically significant difference included the olfactory threshold (means 1,87/ SD 3,3/ t -3,11/ p 0,004) and the combined threshold-discrimination-identification (TDI) scores of Sniffin' Sticks test (means -2,61/ SD 5.26/ t -2.75/ p 0.01) and the self-assessment NOSE (p 0.009) and SNOT-22 (0.031) tests. However, no variable concerning nasal patency revealed statistically significant difference before and after treatment in the study group (p 0.677).</p><p><strong>Conclusions: </strong>Oral PPIs treatment was associated with better olfactory threshold and TDI scores. These results raise the need for further studies, regarding the effect of antireflux medication on patients suffering from LPR who express nasal symptoms and olfaction disfunction.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"19 3","pages":"486-493"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565156/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Maedica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26574/maedica.2024.19.3.486","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Laryngopharyngeal reflux (LPR) is responsible for many otorhinolaryngology manifestations. There is little evidence regarding the LPR impact on olfaction. No other study has investigated the efficacy of proton pump inhibitors (PPIs) on olfaction. We aimed to evaluate the effect of antireflux medication on olfaction and nasal patency in patients with LPR.

Materials and methods: Thirty patients with LPR were recruited. Nasal symptoms were self-evaluated with NOSE and SNOT-22 surveys, while a taste visual analogue scale (VAS) was used for gustation. Olfaction was evaluated with Sniffin' Sticks test and nasal patency with anterior rhinomanometry. After 12 weeks of oral PPIs, the procedure was re-applied and clinical outcomes were compared.

Results: Variables with statistically significant difference included the olfactory threshold (means 1,87/ SD 3,3/ t -3,11/ p 0,004) and the combined threshold-discrimination-identification (TDI) scores of Sniffin' Sticks test (means -2,61/ SD 5.26/ t -2.75/ p 0.01) and the self-assessment NOSE (p 0.009) and SNOT-22 (0.031) tests. However, no variable concerning nasal patency revealed statistically significant difference before and after treatment in the study group (p 0.677).

Conclusions: Oral PPIs treatment was associated with better olfactory threshold and TDI scores. These results raise the need for further studies, regarding the effect of antireflux medication on patients suffering from LPR who express nasal symptoms and olfaction disfunction.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
喉咽反流:抗反流 PPI疗法对鼻塞和嗅觉的影响
目的:喉咽反流 (LPR) 是导致许多耳鼻喉科症状的原因。有关 LPR 对嗅觉影响的证据很少。还没有其他研究调查过质子泵抑制剂 (PPI) 对嗅觉的影响。我们旨在评估抗反流药物对 LPR 患者嗅觉和鼻腔通畅性的影响:招募了 30 名 LPR 患者。使用 NOSE 和 SNOT-22 调查表对鼻部症状进行自我评估,同时使用味觉视觉模拟量表(VAS)对味觉进行评估。嗅觉通过嗅棒测试进行评估,鼻腔通畅度通过前鼻孔测量仪进行评估。在口服 PPIs 12 周后,再次应用该程序并比较临床结果:具有显著统计学差异的变量包括嗅觉阈值(平均值 1,87/ SD 3,3/ t -3,11/ p 0,004)、嗅棒测试的阈值-辨别-识别(TDI)综合评分(平均值 -2,61/ SD 5.26/ t -2.75/ p 0.01)、自我评估 NOSE 测试(p 0.009)和 SNOT-22 测试(0.031)。然而,在研究组中,有关鼻腔通畅性的变量在治疗前后均未显示出显著的统计学差异(P 0.677):结论:口服 PPIs 治疗与嗅觉阈值和 TDI 评分的改善有关。结论:口服 PPIs 治疗与嗅觉阈值和 TDI 评分的改善有关,因此有必要进一步研究抗反流药物对表现出鼻腔症状和嗅觉功能障碍的 LPR 患者的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Laryngopharyngeal Reflux: Effect of Antireflux PPI Therapy on Nasal Congestion and Olfaction. Lumbar Spinal Rahisynthesis with Plif: a Retrospective Study of 58 Patients Demonstrating Imaging and Clinical Outcomes with One Year Follow-up. Mixed Germ Cell Tumor (GCT) of Ovary with Atypical Presentation. Natural Compounds and Cancer: Current Evidences. NF-kB p65 and NF-kB p50 of the Rel Family. A Comparison between Irritable Bowel Syndrome and Inflammatory Bowel Disease Patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1